Etilefrine

Etilefrine is a sympathetic nerve agonist and AMPK activator that selectively targets α1/β1 adrenergic receptors. Etilefrine stimulates α1 adrenergic receptors, leading to contraction of vascular smooth muscle and increased peripheral resistance. Etilefrine also stimulates β1 receptors to enhance myocardial contractility and increase heart rate, thereby increasing blood pressure and improving cardiac output. Etilefrine also bidirectionally regulates the AMPK/Akt pathway and modulates the phosphorylation levels. Etilefrine can be used in cardiovascular research, such as postural hypotension, chylothorax, and improving low cardiac output[1][2][3].

Product Specifications

CAS Number

[709-55-7]

UNSPSC

12352005

Hazard Statement

H302, H312, H315, H319, H332, H335

Target

Adrenergic Receptor; Akt; AMPK

Type

Reference compound

Related Pathways

Epigenetics; GPCR/G Protein; Neuronal Signaling; PI3K/Akt/mTOR

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/etilefrine.html

Purity

97.03

Solubility

DMSO : 40 mg/mL (ultrasonic)

Smiles

OC(CNCC)C1=CC=CC(O)=C1

Molecular Formula

C10H15NO2

Molecular Weight

181.23

Precautions

H302, H312, H315, H319, H332, H335

References & Citations

[1]Chi Xu, et al. Accurate Drug Repositioning through Non-tissue-Specific Core Signatures from Cancer Transcriptomes. Cell Rep. 2018 Oct 9;25 (2) :523-535.e5.|[2]R Yamazaki, et al. Effects of dihydroergotamine and Etilefrine on experimentally-induced postural hypotension in dogs. J Pharmacobiodyn. 1990 Sep;13 (9) :519-24.|[3]Adigun SA, et al. A comparison of the effects of salbutamol, etilefrine and dextran during hypotension and low cardiac output states in rabbit. Clin Exp Pharmacol Physiol. 1984 Nov-Dec;11 (6) :627-43.